Top Wall Street Forecasters Revamp DocuSign Price Expectations Ahead Of Q4 Earnings

Benzinga
13 Mar

DocuSign, Inc. (NASDAQ:DOCU) will release its fourth-quarter financial results, after the closing bell, on Thursday, March 13.

Analysts expect the San Francisco, California-based company to report quarterly earnings at 85 cents per share, up from 76 cents per share in the year-ago period. DocuSign projects quarterly revenue of $761.64 million, compared to $712.39 million a year earlier, according to data from Benzinga Pro.

On Dec. 5, 2024, DocuSign reported third-quarter revenue of $754.8 million, beating the consensus estimate of $745.26 million.

DocuSign shares rose 0.8% to close at $80.13 on Wednesday.

Benzinga readers can access the latest analyst ratings on the Analyst Stock Ratings page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.

Let's have a look at how Benzinga's most-accurate analysts have rated the company in the recent period.

  • JP Morgan analyst Mark Murphy upgraded the stock from Underweight to Neutral and raised the price target from $70 to $75 on March 10, 2025. This analyst has an accuracy rate of 73%.
  • JMP Securities analyst Patrick Walravens reiterated a Market Outperform rating with a price target of $124 on Jan. 7, 2025. This analyst has an accuracy rate of 61%.
  • HSBC analyst Stephen Bersey downgraded the stock from Hold to Reduce on Dec. 6, 2024. This analyst has an accuracy rate of 61%.
  • Citigroup analyst Tyler Radke maintained a Buy rating and raised the price target from $87 to $113 on Dec. 6, 2024. This analyst has an accuracy rate of 66%.
  • UBS analyst Karl Keirstead maintained a Neutral rating and increased the price target from $60 to $100 on Dec. 6, 2024. This analyst has an accuracy rate of 74%.

Considering buying DOCU stock? Here’s what analysts think:

Read This Next:

  • Top 2 Industrials Stocks That May Collapse In March

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10